348 related articles for article (PubMed ID: 25116228)
21. Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.
Applebaum MA; Henderson TO; Lee SM; Pinto N; Volchenboum SL; Cohn SL
Pediatr Blood Cancer; 2015 Jan; 62(1):128-33. PubMed ID: 25251613
[TBL] [Abstract][Full Text] [Related]
22. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
Rihani R; Bazzeh F; Faqih N; Sultan I
Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
[TBL] [Abstract][Full Text] [Related]
23. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Pukkala E; Weiderpass E; Olsen JH; Tracey E; McBride ML; Brewster DH; Pompe-Kirn V; Tonita JM; Kliewer EV; Chia KS; Jonasson JG; Martos C; Magnani C; Boffetta P
Eur J Cancer; 2008 Apr; 44(6):830-9. PubMed ID: 18329873
[TBL] [Abstract][Full Text] [Related]
24. Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987-2004) from the childhood cancer registry of the Rhône-Alpes region (ARCERRA) in France.
Berger C; Trombert-Paviot B; Casagranda L; Mialou V; Frappaz D; Plantaz D; Collardeau-Frachon S; Freycon F
Pediatr Hematol Oncol; 2011 Aug; 28(5):364-79. PubMed ID: 21736475
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
26. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
27. Salivary gland second cancer after bone sarcoma treatment.
Longhi A; Errani C; Gambarotti M; Ferrari C; Kreshak J; Panagopoulos GN; Mavrogenis AF; Donati D
Eur J Orthop Surg Traumatol; 2015 Oct; 25(7):1201-4. PubMed ID: 26174415
[TBL] [Abstract][Full Text] [Related]
28. Second malignancy risk among pediatric, adolescent, and young adult survivors of fusion-positive and fusion-negative sarcomas: Results from the SEER database, 1992 through 2012.
Lupo PJ; Brown AL; Hettmer S
Cancer; 2016 Nov; 122(22):3492-3500. PubMed ID: 27481314
[TBL] [Abstract][Full Text] [Related]
29. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
[TBL] [Abstract][Full Text] [Related]
30. Second malignancies in patients with Ewing Sarcoma Family of Tumors: A population-based study.
Sultan I; Rihani R; Hazin R; Rodriguez-Galindo C
Acta Oncol; 2010; 49(2):237-44. PubMed ID: 20100158
[TBL] [Abstract][Full Text] [Related]
31. Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence.
Devarahally SR; Severson RK; Chuba P; Thomas R; Bhambhani K; Hamre MR
Pediatr Hematol Oncol; 2003 Dec; 20(8):617-25. PubMed ID: 14578032
[TBL] [Abstract][Full Text] [Related]
32. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
33. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
Kutsenko A; Berrington de Gonzalez A; Curtis RE; Rajaraman P
Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745
[TBL] [Abstract][Full Text] [Related]
34. Secondary malignant neoplasms following radiotherapy for primary cancer in children and young adults.
Harbron RW; Feltbower RG; Glaser A; Lilley J; Pearce MS
Pediatr Hematol Oncol; 2014 Apr; 31(3):259-67. PubMed ID: 24087931
[TBL] [Abstract][Full Text] [Related]
35. Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group.
Kowalczyk J; Nurzyńska-Flak J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Pawelec K
Med Sci Monit; 2004 Mar; 10(3):CR117-22. PubMed ID: 14976453
[TBL] [Abstract][Full Text] [Related]
36. Second malignant neoplasms in childhood cancer survivors in a tertiary paediatric oncology centre in Hong Kong, China.
Sun WF; Cheng FW; Lee V; Leung WK; Shing MK; Yuen PM; Li CK
Chin Med J (Engl); 2011 Nov; 124(22):3686-92. PubMed ID: 22340225
[TBL] [Abstract][Full Text] [Related]
37. Second Malignant Neoplasms in Childhood Cancer Survivors Treated in a Tertiary Paediatric Oncology Centre.
Lim JW; Yeap FS; Chan YH; Yeoh AE; Quah TC; Tan PL
Ann Acad Med Singap; 2017 Jan; 46(1):11-19. PubMed ID: 28182813
[No Abstract] [Full Text] [Related]
38. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
39. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group.
Breslow NE; Takashima JR; Whitton JA; Moksness J; D'Angio GJ; Green DM
J Clin Oncol; 1995 Aug; 13(8):1851-9. PubMed ID: 7636528
[TBL] [Abstract][Full Text] [Related]
40. The epidemiology of osteosarcoma.
Ottaviani G; Jaffe N
Cancer Treat Res; 2009; 152():3-13. PubMed ID: 20213383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
